[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349071-105":59,"doc-detail-349071-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","bufalin-inhibits-the-pi3kakt-pathway-by-targeting-gtf3c4-to-impede-breast-cancer-progression","Bufalin Inhibits the PI3K/AKT Pathway by Targeting GTF3C4 to Impede Breast Cancer Progression","","Breast cancer incidence is increasing globally, creating urgent needs to reduce treatment side effects and overcome drug resistance. Bufalin, a bufadienolide compound, suppresses malignant proliferation of MDA-MB-231 and MCF-7 cells and protects mice from breast cancer. GTF3C4 is identified as its target and is overexpressed in breast cancer with poor prognosis. Mechanistic assays verify bufalin binding to GTF3C4 and show reduced PI3K/AKT signaling, decreased tumor growth, and enhanced apoptosis. Single-cell RNA sequencing indicates remodeling of the tumor microenvironment.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/bufalin-inhibits-the-pi3kakt-pathway-by-targeting-gtf3c4-to-impede-breast-cancer-progression/349071/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/bufalin-inhibits-the-pi3kakt-pathway-by-targeting-gtf3c4-to-impede-breast-cancer-progression/349071.png","ImageObject",300,407,{"name":92,"@type":93},"วิน","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main mechanism proposed for bufalin in this study?","Question",{"text":112,"@type":113},"Bufalin targets GTF3C4 and inhibits the PI3K/AKT signaling pathway, leading to suppression of breast cancer progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the target protein GTF3C4 identified and validated?",{"text":117,"@type":113},"GTF3C4 was identified by Limited Proteolysis-Mass Spectrometry, and its specific binding to bufalin was verified using cell thermal shift assays, drug affinity response target stability assays, and surface plasmon resonance.",{"name":119,"@type":110,"acceptedAnswer":120},"What effects does bufalin have on the tumor microenvironment?",{"text":121,"@type":113},"Single-cell RNA sequencing shows bufalin reduces the proportions of macrophages, neutrophils, and monocytes and alters receptor-ligand signal strengths between cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},349071,1790153360,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336475104736,"https://ap-avatar.wpscdn.com/avatar/22000c4c5e0e5b17e70?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786591360781797222","Advanced Science    \n[www.advancedscience.com](www.advancedscience.com)  \n RESEARCH ARTICLE   \nBufalin Inhibits the PI3K/AKT Pathway by Targeting GTF3C4 to Impede Breast Cancer Progression  \nSiyu Guo1  Xiaodong Chen1  Jingyuan Zhang1  Siyun Yang1 Qinglin Li3  Jiarui Wu1   \nHaojia Wang1  Shan Lu1  \n Jiying Zhou1  Peiying Lu1 Yifei Gao1  Zhengsen Jin1  \nJiangying Liu1  Keyan Chai1 Xiaoyu Tao1  Zhongdong Hu2  \n1 Department of Clinical Chinese Pharmacy, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China  2Modern Research Center For Traditional Chinese Medicine, Beijing Institute of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China   \n3 Hangzhou Institute of Medicine (HIM), Zhejiang Cancer Hospital, Chinese Academy of Sciences, Hangzhou, Zhejiang, China Correspondence: Zhongdong Hu ([zdhu@bucm.edu.cn](zdhu@bucm.edu.cn))  Qinglin Li (qinglin200886@126.com)  Jiarui Wu (exogamy@163.com)  \nReceived: 17 April 2025  Revised: 2 July 2025  Accepted: 2 February 2026  \nKeywords: breast cancer | Bufalin | GTF3C4 | PI3K/AKT pathway | tumor microenvironment  \nABSTRACT  \nBreast cancer incidence is rising globally, presenting challenges such as treatment side effects and drug resistance. Bufalin is abufadienolides compound with potential anti-cancer effects. This study shows that bufalin inhibits malignant proliferation of MDA-MB-231 and MCF-7 cells and protects mice against breast cancer. Of note, GTF3C4 was identified as the target protein by Limited Proteolysis-Mass Spectrometry. GTF3C4 is overexpressed in breast cancer and associated with poor prognosis. RNA sequencing analysis reveals that the PI3K/AKT signaling pathway is a key contributor. Using cell thermal shift assays, drug affinity response target stability assays, and surface plasmon resonance, it was verified that bufalin can specifically bind to GTF3C4 . Bufalin reduces GTF3C4 protein levels in vivo and in vitro, effectively inhibiting breast cancer progression by suppressing the PI3K/AKT signaling pathway. After the knockdown of GTF3C4, the PI3K/AKT signaling pathway is also suppressed, thereby inhibiting the proliferation of breast cancer cells and promoting apoptosis. Single-cell RNA sequencing results indicated that bufalin reduces the proportions of macrophages, neutrophils, and monocytes, and affects the strength of receptor-ligand signals between cells. Collectively, this study demonstrates that bufalin targets GTF3C4 to inhibit the PI3K/AKT pathway and remodels the tumor microenvironment, thereby hindering the malignant progression of breast cancer.  \n1  Introduction  \nBreast cancer has the highest incidence among malignant tumors in women, accounting for 32% of all female malignancie [1] . Despite improvements in the overall survival and prognosis of breast cancer patients in recent years, oncologists still face significant challenges in reducing the incidence of breast cancer and preventing recurrence and metastasis [2] . Breast cancer is a highly heterogeneous malignancy, exhibiting  \nsignificant morphological and molecular heterogeneity both between tumors and within individual tumors [3] . Therefore, there is an urgent need to explore new treatment strategies to enhance therapeutic efficacy and improve the quality of life for patients. In recent years, research into the molecular mechanisms of breast cancer has deepened, providing new insights for the development of novel targeted drugs [4–6] . A comprehensive understanding of the biological characteristics of breast cancer and the regulatory mechanisms of its  \n\n| Siyu Guo and Xiaodong Chen contributed equally to this work.\u003Cbr>|\n| --- |\n| This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.\u003Cbr>© 2026 The Author(s). Advanced Science published by Wiley-VCH GmbH |\n\nAdvanced Science, 2026; 13:e07008  \n[ht","cbCaikJK1Rrj55wf","https://ap.wps.com/l/cbCaikJK1Rrj55wf","pdf",6835944,18,"English","# Abstract\n# Introduction\n## Bufonis venenum and bufalin background\n## Rationale for targeting GTF3C4 and PI3K/AKT\n## Tumor microenvironment and single-cell analysis","[{\"question\":\"What is the main mechanism proposed for bufalin in this study?\",\"answer\":\"Bufalin targets GTF3C4 and inhibits the PI3K/AKT signaling pathway, leading to suppression of breast cancer progression.\"},{\"question\":\"How was the target protein GTF3C4 identified and validated?\",\"answer\":\"GTF3C4 was identified by Limited Proteolysis-Mass Spectrometry, and its specific binding to bufalin was verified using cell thermal shift assays, drug affinity response target stability assays, and surface plasmon resonance.\"},{\"question\":\"What effects does bufalin have on the tumor microenvironment?\",\"answer\":\"Single-cell RNA sequencing shows bufalin reduces the proportions of macrophages, neutrophils, and monocytes and alters receptor-ligand signal strengths between cells.\"}]","Bufalin Inhibits the PI3K/AKT Pathway by Targeting GTF3C4 to Impede Breast Cancer Progression | PDF",1790081494,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/818ad8e52fbf3313561f368620fdbf90.webp",983,1283,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/123366fc2bdd2088c5f7b49d00b6ce56.webp",982,1281,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/78bb2c8c0a219d91c227a3d114b3d05c.webp",981,1280,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9d18c7382e810e603d28a2cc27973d94.webp",980,1279]